Literature DB >> 20581170

Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.

Douglas Arenberg1, Tracy R Luckhardt, Shannon Carskadon, Liujian Zhao, Mohammad A Amin, Alisa E Koch.   

Abstract

RATIONALE: Tissue injury and repair involve highly conserved processes governed by mechanisms that can be co-opted in tumors. We hypothesized that soluble factors released during the repair response to lung injury would promote orthotopic tumor growth.
OBJECTIVES: To determine whether lung injury promoted growth of orthotopic lung tumors and to study the molecular mechanisms.
METHODS: We initiated lung injury in C57Bl6 mice using different stimuli, then injected Lewis lung carcinoma cells during the repair phase. We assessed tumor growth 14 days later. We measured tumor angiogenesis, cytokine expression, proliferation, and apoptosis.
MEASUREMENTS AND MAIN RESULTS: Regardless of the mechanism, injured lungs contained more numerous and larger tumors than sham-injured lungs. Tumors from injured lungs were no more vascular, but had higher levels of proliferation and reduced rates of apoptosis. The cytokine macrophage migration inhibitory factor (MIF) was highly expressed in both models of tissue injury. We observed no increase in tumor growth after lung injury in MIF knockout mice. We induced lung-specific overexpression of MIF in a double-transgenic mouse, and observed that MIF overexpression by itself was sufficient to accelerate the growth of orthotopic Lewis lung carcinoma tumors.
CONCLUSIONS: Lung injury leads to increased expression of the cytokine MIF, which results in protection from apoptosis and increased proliferation in orthotopic tumors injected after the acute phase of injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581170      PMCID: PMC2970845          DOI: 10.1164/rccm.201001-0120OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  58 in total

1.  Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.

Authors:  R Hubbard; A Venn; S Lewis; J Britton
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

3.  Alpha-thrombin stimulates expression of macrophage migration inhibitory factor in skin fibroblasts.

Authors:  T Shimizu; A Ohkawara; Y Mizue; J Nishihira
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

4.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

5.  Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.

Authors:  E S White; S R Strom; N L Wys; D A Arenberg
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

6.  Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts.

Authors:  R Abe; T Shimizu; A Ohkawara; J Nishihira
Journal:  Biochim Biophys Acta       Date:  2000-01-03

Review 7.  Mechanisms in COPD: differences from asthma.

Authors:  P J Barnes
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

8.  Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.

Authors:  A Kamimura; M Kamachi; J Nishihira; S Ogura; H Isobe; H Dosaka-Akita; A Ogata; M Shindoh; T Ohbuchi; Y Kawakami
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

9.  Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells.

Authors:  K Meyer-Siegler
Journal:  J Interferon Cytokine Res       Date:  2000-09       Impact factor: 2.607

10.  A proinflammatory cytokine inhibits p53 tumor suppressor activity.

Authors:  J D Hudson; M A Shoaibi; R Maestro; A Carnero; G J Hannon; D H Beach
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

View more
  13 in total

1.  Extracellular Matrix Receptor Expression in Subtypes of Lung Adenocarcinoma Potentiates Outgrowth of Micrometastases.

Authors:  Laura E Stevens; William K C Cheung; Sally J Adua; Anna Arnal-Estapé; Minghui Zhao; Zongzhi Liu; Kelly Brewer; Roy S Herbst; Don X Nguyen
Journal:  Cancer Res       Date:  2017-02-14       Impact factor: 12.701

Review 2.  Update in acute lung injury and critical care 2010.

Authors:  István Vadász; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

3.  Update in lung cancer and oncological disorders 2010.

Authors:  Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-08-01       Impact factor: 21.405

4.  Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.

Authors:  Leona Mawhinney; Michelle E Armstrong; Ciaran O' Reilly; Richard Bucala; Lin Leng; Gunter Fingerle-Rowson; Darren Fayne; Michael P Keane; Aisling Tynan; Lewena Maher; Gordon Cooke; David Lloyd; Helen Conroy; Seamas C Donnelly
Journal:  Mol Med       Date:  2015-04-16       Impact factor: 6.354

5.  Interplay between aging, lung inflammation/remodeling, and fibronectin EDA in lung cancer progression.

Authors:  John C Greenwell; Edilson Torres-Gonzalez; Jeffrey D Ritzenthaler; Jesse Roman
Journal:  Cancer Biol Ther       Date:  2020-11-23       Impact factor: 4.742

Review 6.  Role of macrophage migration inhibitory factor in age-related lung disease.

Authors:  Maor Sauler; Richard Bucala; Patty J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-08       Impact factor: 5.464

7.  Identification of differentially expressed inflammatory factors in Wilms tumors and their association with patient outcomes.

Authors:  Fei Guo; Junjie Zhang; Lei Wang; Wei Zhao; Jiekai Yu; Shu Zheng; Jiaxiang Wang
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

8.  Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.

Authors:  Yubiao Guo; Junna Hou; Yifeng Luo; Dujuan Wang
Journal:  Cancer Cell Int       Date:  2013-03-24       Impact factor: 5.722

9.  Yin Yang gene expression ratio signature for lung cancer prognosis.

Authors:  Wayne Xu; Shantanu Banerji; James R Davie; Fekadu Kassie; Douglas Yee; Robert Kratzke
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

10.  Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.

Authors:  Xiao-Hui Huang; Wei-Hua Jian; Zhao-Feng Wu; Jie Zhao; Hua Wang; Wen Li; Jin-Tang Xia
Journal:  Oncotarget       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.